E-Mail Updates

Click here to join
our Electronic Communications.


Take a look.

Interview with Frédéric Triebel and Marc Voigt

CNBC - interview Marc Voigt

Mode of Action of eftilagimod alpha (“IMP321”)

Sky Business Interview with Marc Voigt, 25.11.15

Lucy Turnbull's Interview with The Business

Marc Voigt’s Interview with Sky Business News - 16.05.14

Manufacturing of CVac